A detailed history of Northern Trust Corp transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 394,035 shares of PYXS stock, worth $665,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
394,035
Previous 128,396 206.89%
Holding current value
$665,919
Previous $424,000 241.04%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.83 - $3.94 $751,758 - $1.05 Million
265,639 Added 206.89%
394,035 $1.45 Million
Q2 2024

Aug 14, 2024

BUY
$3.06 - $5.58 $205,515 - $374,763
67,162 Added 109.68%
128,396 $424,000
Q1 2024

May 14, 2024

BUY
$2.03 - $6.59 $1,930 - $6,267
951 Added 1.58%
61,234 $260,000
Q4 2023

Feb 13, 2024

BUY
$1.4 - $2.09 $10,551 - $15,752
7,537 Added 14.29%
60,283 $108,000
Q3 2023

Nov 13, 2023

BUY
$1.6 - $2.78 $8,564 - $14,881
5,353 Added 11.29%
52,746 $104,000
Q2 2023

Aug 11, 2023

BUY
$2.46 - $4.07 $39,079 - $64,656
15,886 Added 50.42%
47,393 $121,000
Q1 2023

May 15, 2023

BUY
$1.38 - $6.0 $7,050 - $30,654
5,109 Added 19.35%
31,507 $126,000
Q3 2022

Nov 14, 2022

BUY
$1.88 - $3.03 $16,273 - $26,227
8,656 Added 48.79%
26,398 $52,000
Q2 2022

Aug 12, 2022

SELL
$2.02 - $4.53 $142,585 - $319,759
-70,587 Reduced 79.91%
17,742 $42,000
Q1 2022

May 13, 2022

SELL
$4.04 - $11.43 $3,660 - $10,355
-906 Reduced 1.02%
88,329 $357,000
Q4 2021

Feb 08, 2022

BUY
$8.39 - $13.64 $748,681 - $1.22 Million
89,235 New
89,235 $979,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.